Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
03/20/1996 | EP0701606A1 Method of enhancing thrombolysis |
03/20/1996 | EP0701573A1 Genetically engineered immunoglobulins |
03/20/1996 | EP0701570A1 Thermoresistant alpha-1-antitrypsin mutein |
03/20/1996 | EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
03/20/1996 | EP0701401A1 Adenoviral vectors including dna encoding lung surfactant protein |
03/20/1996 | EP0355140B1 Human monoclonal anti-hiv-i-antibodies |
03/20/1996 | EP0280710B1 Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids |
03/20/1996 | CN1119027A Method of controlling insects in plants |
03/20/1996 | CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
03/20/1996 | CN1118983A Tomato spotted wilt virus |
03/19/1996 | US5500362 Chimeric antibody with specificity to human B cell surface antigen |
03/19/1996 | US5500360 RNA transformation vector |
03/19/1996 | US5500348 Basophil-binding monoclonal antibody, method for separation of basophils, method for chemical mediator release from basophils, and method for testing release of basophil-derived chemical mediators |
03/19/1996 | US5500347 Diagnosis of cancerous tumors and determination of their origin |
03/19/1996 | US5500215 Immunology |
03/19/1996 | CA2002515C Expression enhancer and use thereof to increase the yield in the expression of recombinant genes |
03/19/1996 | CA1338171C Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical |
03/17/1996 | CA2158395A1 Coccidiosis poultry vaccine |
03/14/1996 | WO1996007754A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
03/14/1996 | WO1996007753A1 Amino acid conjugate |
03/14/1996 | WO1996007745A2 Mycobacteria functional screening and/or expression vectors |
03/14/1996 | WO1996007744A1 A method of improved production of insulin-like growth factor |
03/14/1996 | WO1996007740A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody |
03/14/1996 | WO1996007739A2 Interleukin-1 type 3 receptors |
03/14/1996 | WO1996007738A2 Modified human c3 proteins |
03/14/1996 | WO1996007735A1 Novel deoxyribonuclease |
03/14/1996 | WO1996007734A2 Recombinant adenovirus comprising a chimeric penton base protein |
03/14/1996 | WO1996007728A1 Production and secretion of recombinant fibrinogen by yeast |
03/14/1996 | WO1996007313A1 A plant promoter useful for directing the expression of foreign proteins to the plant epidermis |
03/14/1996 | WO1996006168A3 Retinoblastoma protein-interacting zinc finger proteins |
03/14/1996 | WO1996005306A3 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
03/14/1996 | WO1996004378A3 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
03/14/1996 | WO1996001425A3 Assay for inhibitors of dp-1 and other dp proteins |
03/14/1996 | WO1995035376A3 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
03/14/1996 | WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
03/14/1996 | WO1995034651A3 Corticotropin-releasing factor2 receptors |
03/14/1996 | CA2199609A1 Interleukin-1 type 3 receptors |
03/14/1996 | CA2198935A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody |
03/14/1996 | CA2198928A1 Production and secretion of recombinant fibrinogen by yeast |
03/14/1996 | CA2198870A1 A plant promoter useful for directing the expression of foreign proteins to the plant epidermis |
03/14/1996 | CA2198861A1 Recombinant adenovirus comprising a chimeric penton base protein |
03/14/1996 | CA2197888A1 Modified human c3 proteins |
03/13/1996 | EP0700998A1 Recombinant mersacidin and a method for production |
03/13/1996 | EP0700997A1 Production in bacteria and yeast of hemoglobin and analogues thereof |
03/13/1996 | EP0700994A1 Anti-igf-i monoclonal antibody |
03/13/1996 | EP0700993A1 Anti-thymosin alpha 1 monoclonal antibody-producing hybridoma |
03/13/1996 | EP0700446A1 Antibodies specific for dcc gene product |
03/13/1996 | EP0700445A1 Stress proteins and uses therefor |
03/13/1996 | EP0700444A1 Immunotoxins comprising gelonin and an antibody |
03/13/1996 | EP0700443A1 Cho cell sialidase disrupted by recombinant dna technology |
03/13/1996 | EP0700441A1 Multiple sclerosis virus |
03/13/1996 | EP0700440A1 Regulator of contact-mediated hemolysin |
03/13/1996 | EP0700439A1 Lymphocyte chemoattractant factor and uses thereof |
03/13/1996 | EP0700438A1 Opioid receptors: compositions and methods |
03/13/1996 | EP0700433A1 A method for hydrolysing proteins |
03/13/1996 | EP0700430A1 Methods for selectively stimulating proliferation of t cells |
03/13/1996 | EP0700402A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
03/13/1996 | EP0700401A1 Human calcium sensor |
03/13/1996 | EP0700305A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
03/13/1996 | EP0567562B1 Methods for detecting glucagon antagonists |
03/13/1996 | EP0550691B1 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides |
03/13/1996 | EP0528932B1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis |
03/13/1996 | EP0502962B1 Hirudinmuteins and their polyalkylene glycol conjugates |
03/13/1996 | EP0491007B1 Structural alterations of the egf receptor gene in human gliomas |
03/13/1996 | EP0436545B1 Therapeutic methods using catalytic antibodies |
03/13/1996 | EP0435911B1 Cell culture medium for enhanced cell growth, culture longevity and product expression |
03/13/1996 | EP0428602B1 Polypeptides and dna encoding same |
03/12/1996 | US5498697 Protein possessing metastasis-inhibitory activity |
03/12/1996 | US5498538 Totally synthetic affinity reagents |
03/12/1996 | US5498499 Peptides and antibodies that inhibit platelet adhesion |
03/10/1996 | CA2145905A1 Anti-thymosin .alpha.1 monoclonal antibody-producing hybridoma |
03/07/1996 | WO1996007103A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
03/07/1996 | WO1996007096A1 AN IN VITRO SYSTEM FOR DETERMINING FORMATION OF Aβ AMYLOID |
03/07/1996 | WO1996006943A1 Cell cycle regulated repressor and dna element |
03/07/1996 | WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | WO1996006937A1 Improvements in production of proteins in host cells |
03/07/1996 | WO1996006933A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
03/07/1996 | WO1996006932A1 Plant transcription regulators from circovirus |
03/07/1996 | WO1996006862A1 Gabaa receptor epsilon subunit |
03/07/1996 | WO1996006861A1 Trefoil peptide dimer |
03/07/1996 | WO1996006859A1 Trophic factors for central nervous system regeneration |
03/07/1996 | WO1996006627A1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
03/07/1996 | WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
03/07/1996 | WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
03/07/1996 | WO1995032291A3 Hepatitis g virus and molecular cloning thereof |
03/07/1996 | DE19532001A1 New antibacterial peptide, moricin, from silkworms |
03/07/1996 | CA2198587A1 Trophic factors for central nervous system regeneration |
03/07/1996 | CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound |
03/07/1996 | CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
03/07/1996 | CA2198345A1 Improvements in production of proteins in host cells |
03/07/1996 | CA2198080A1 Cell cycle regulated repressor and dna element |
03/07/1996 | CA2197452A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases |
03/07/1996 | CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
03/06/1996 | EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4 |
03/06/1996 | EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
03/06/1996 | EP0699758A1 Prototype felv isolates for use in disease models and vaccines |
03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
03/06/1996 | EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |